This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: Novartis institutes for BioMedical research

Cardiovascular research 2018 handbook: <br>Clinical trials in the UK from a commercial perspective

September 2018 doi:10.5837/bjc.2018.s11

Cardiovascular research 2018 handbook:
Clinical trials in the UK from a commercial perspective

This article is based on a presentation made by Dr Mark Toms and Dr Tom Thuren

Abstract

This investment in research also benefits the UK economy providing employment, trade, and addressing shortfalls in STEM skills (Science, Technology, Engineering, and Mathematics). In addition to giving patients faster access to treatments, getting efficacious and safe medicines registered more efficiently enables the trial sponsor to gain reimbursement for those medications sooner. Evolving bio-pharmaceutical model Medical research changed dramatically with the discovery of the structure of DNA and the subsequent understanding of genetic code, with DNA sequencing and amplification. This has led to medicines becoming increasingly personalised

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now